Promising Results for Imlunestrant in Advanced ...

By Rene Pretorius

December 16, 2024

The study outlined in the news release from Eli Lilly and Company focuses on the efficacy and safety of imlunestr...
CMS Price Negotiations: Bridging the Gap in US Drug Pricing
Access to Anti-Obesity Medication for Medicare and Medicaid
Zepbound Outperforms Wegovy in Weight Loss Trial
Canada’s Drug Agency Launches Consultation on New Methods Guide for Hea...
Sanofi’s 340B Rebate Model: A Joint Effort to Reform Drug Pricing Pract...
Lawsuits Challenge 340B Drug Pricing Program: Eli Lilly and J&J vs. HRSA
Enhancing Rare Disease Decision-Making Through Integrated Data Linkage in Canada
AI-Ready Dataset Revolutionizes Type 2 Diabetes Research
Improving Cervical Cancer Screening: HPV Self-Collection Tests
Endometrial Cancer Treatment Innovations
Ozempic Shows Promise in Reducing Alzheimer’s Risk
Neoadjuvant Chemotherapy: Transforming Treatment for Advanced Ovarian Cancer